eupafolin

07/21/2015 - "These results suggest that eupafolin may represent a novel therapeutic agent targeting epithelial activation in lung inflammation."
01/01/2016 - "The aim of this study was to examine the anti-inflammatory effects of eupafolin in lipopolysaccharide (LPS)-treated RAW264.7 macrophages and LPS-induced mouse skin and lung inflammation models and to identify the mechanism underlying these effects. "
07/21/2015 - "The protective effect of eupafolin against TNF-α-induced lung inflammation via the reduction of intercellular cell adhesion molecule-1 expression."
12/01/2022 - "Nepetin reduces virulence factors expression by targeting ClpP against MRSA-induced pneumonia infection."

12/01/2020 - "The present study aimed to investigate the protective effects of eupafolin on cerebral ischemia/reperfusion (I/R) injury in rats and its possible underlying mechanisms. "
12/01/2020 - "Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway."

01/01/2013 - "Anti-enteroviral potency of KGS EA fraction and eupafolin shows the clinical potential against EV71 and CoxA16 infection. "
12/01/2022 - "In conclusion, we determined that nepetin is a ClpP inhibitor and an effective lead compound for the development of a virulence factor-based treatment for MRSA infection."
12/01/2022 - "Nepetin reduces virulence factors expression by targeting ClpP against MRSA-induced pneumonia infection."
01/10/2022 - "perfoliatum extract and its few bioactive components i.e., quercetin, caffeic acid and eupafolin against wild primary clinical isolate of DENV-2 infection in an in vitro model. "

12/01/2020 - "The results revealed that eupafolin decreased the neurological score, relieved encephaledema and decreased infarct volume. "

01/01/2019 - "The animal study showed that the injection of eupafolin in patient-derived xenograft (PDX) mouse effectively suppressed tumor growth. "
01/01/2017 - "Our study was the first to report the activity of eupafolin against tumor angiogenesis as well as the underlying mechanism by which eupafolin to exert its anti-angiogenic activity."
01/01/2023 - "Eupafolin is documented to possess anti-tumor efficacy, which prompts efforts to uncover its impacts on the pathology of diseases including cancers. "
01/01/2017 - "The results of HCC xenograft experiments demonstrated eupafolin remarkably inhibited tumor growth and tumor angiogenesis in vivo, suggesting the antitumor activity exerted by eupafolin was closely correlated with its potency on tumor angiogenesis. "
01/01/2017 - "However, the function and the mechanism of eupafolin to exert its antitumor activity, especially its effect on tumor angiogenesis, have not been elucidated. "